Source: Annual Congress 2006 - Pulmonary circulation: inflammation and remodelling
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Paddenberg, U. Pfeil, A. Goldenberg, P. Faulhammer, W. Kummer (Giessen, Germany). Hypoxia-induced increase in NO production and eNOS expression by murine pulmonary microvascular endothelial cells. Eur Respir J 2006; 28: Suppl. 50, 4650

Member's Comments

No comment yet.

Related content which might interest you: Alkalosis induce eNOS activation in human pulmonary arterial endothelial cells Source: Eur Respir J 2001; 18: Suppl. 33, 73s Year: 2001 Hyperoxia-induced gene expression and apoptosis of human pulmonary artery endothelial cells Source: Eur Respir J 2006; 28: Suppl. 50, 397s Year: 2006 Apoptosis and cell proliferation in chronic hypoxic pulmonary hypertension Source: Lung Science Conference 2007 - Translational research in pulmonary disease: Hypoxia-driven mechanisms Year: 2007 The effects of hypoxia on the cells of the pulmonary vasculature Source: Eur Respir J 2007; 30: 364-372 Year: 2007 Imbalance between vascular endothelial growth factor and endostatin in emphysema Source: Eur Respir J 2003 Oct 01;22(4):609-612 Year: 2003 Inhibition of the Rho-kinase attenuates hypoxia-induced angiogenesis in the pulmonary circulation Source: Annual Congress 2006 - Pulmonary circulation: inflammation and remodelling Year: 2006 Implication of aquaporin-1 in the stress response of human pulmonary microvascular endothelial cells Source: International Congress 2019 – Biomarkers, laboratory findings and pre-clinical data in acute respiratory failure Year: 2019 VEGF reduces pulmonary hypertension and vascular remodeling in pulmonary fibrosis through reduced endothelial apoptosis Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009 Involvement of FHL1 in vascular remodelling Source: Annual Congress 2006 - Lung vascular and parenchymal remodeling Year: 2006 Effects of hypoxia on VEGF and VEGF-R expression by human alveolar epithelial (ATII) and human pulmonary microvascular endothelial (HMVEC-l) cells Source: Annual Congress 2008 - Border patrol: the alveolar barrier in lung injury Year: 2008 PDGF promotes pulmonary artery smooth muscle cell proliferation and migration in pulmonary arterial hypertension Source: Annual Congress 2006 - Signalisation in the pulmonary vasculature: new pathways and wrong signals Year: 2006 The pro-proliferative phenotype of pulmonary microvascular endothelium Source: Research Seminar 2005 - Pulmonary Circulation: Molecular Determinants of Pulmonary Vascular Remodelling Year: 2005 Regulation of connexins by hypoxia in rat pulmonary vascular cells in an in vitro model of pulmonary hypertension Source: International Congress 2017 – Experimental PH Year: 2017 Shroom expression is attenuated in pulmonary arterial hypertension Source: Eur Respir J 2008; 32: 871-880 Year: 2008 IL-11 promotes pulmonary vascular remodeling and lung fibrosis through the activation of endothelial to mesenchymal transition. Source: Virtual Congress 2020 – Translational aspects of idiopathic pulmonary fibrosis Year: 2020 Effect of BMPRII on endothelial function in human lung microvascular endothelial cells Source: International Congress 2018 – Experimental research in pulmonary hypertension Year: 2018 Wnt5a down-regulated hypoxia-induced pulmonary arterial smooth muscle cell proliferation by inhibition of β-catenin Source: Annual Congress 2010 - Pathobiology of pulmonary hypertension Year: 2010 Decreased VEGF concentration in lung tissue and vascular injury during ARDS Source: Eur Respir J 2005; 25: 139-146 Year: 2005 The effect of ASK1 inhibition on hypoxia-induced pulmonary artery fibroblast activation and associated paracrine effects on vascular smooth muscle cells Source: International Congress 2016 – The nature of pulmonary hypertension Year: 2016 Increased binding activity of hypoxia inducible factor (HIF)-1α to vascular endothelial growth factor (VEGF) promoter region mediates enhanced vascular permeability in the lung of cystic fibrosis (CF) patients Source: Eur Respir J 2003; 22: Suppl. 45, 173s Year: 2003